ReCon Marketing Solutions is a full-service managed markets marketing firm offering strategic planning, market research, project management, creative services, and technology solutions to pharmaceutical clients. The firm's 40 staff members are experienced in managed care and agencies. ReCon advises clients on strategic access to payers, value communication to providers and patients, and expanding their market reach. Services include rapid surveys of payers, qualitative interviews, and strategy committees comprising leading healthcare experts. The goal is to help clients position their portfolios and products for preferred formulary status through differentiated clinical messaging.
BioTech Journey through the Phases of Commercializing a ProductCBG Benefits
This presentation was delivered by Breck Arnzen of the ArnzenGroup and Susan Nemetz of The NemetzGroup at the HR BioTech Connect Group meeting in January 2013.
They shared a variety of guidance to help companies navigate the process of commercializing a product in the BioTech industry.
The 2112 Group is a business strategy firm focused on improving the performance of technology companies’ direct and indirect channels through our portfolio of market-leading products and services.
We leverage proprietary intelligence with qualitative research, market analysis, tools, and enablement programs.
By looking at the technology market from the viewpoint of vendors, partners, and end users, The 2112 Group is uniquely positioned to develop go-to-market strategies that are beneficial to all parties from both a channel and enterprise perspective. With a presence in the United Kingdom, 2112 has established an international footprint.
New Product Development Philosophy IB Work BetterStephen Tavares
This presentation outlines Philosophy IB's offerings in the New Product Development space including governance and process design and outsourced project management.
BioTech Journey through the Phases of Commercializing a ProductCBG Benefits
This presentation was delivered by Breck Arnzen of the ArnzenGroup and Susan Nemetz of The NemetzGroup at the HR BioTech Connect Group meeting in January 2013.
They shared a variety of guidance to help companies navigate the process of commercializing a product in the BioTech industry.
The 2112 Group is a business strategy firm focused on improving the performance of technology companies’ direct and indirect channels through our portfolio of market-leading products and services.
We leverage proprietary intelligence with qualitative research, market analysis, tools, and enablement programs.
By looking at the technology market from the viewpoint of vendors, partners, and end users, The 2112 Group is uniquely positioned to develop go-to-market strategies that are beneficial to all parties from both a channel and enterprise perspective. With a presence in the United Kingdom, 2112 has established an international footprint.
New Product Development Philosophy IB Work BetterStephen Tavares
This presentation outlines Philosophy IB's offerings in the New Product Development space including governance and process design and outsourced project management.
The basics of launching a pharmaceutical drug-
Based on studies done on the practices of 13 top pharmaceutical companies in the world.
For more, write to info@markivmedical.com
Concept to commercialization document gives an insight into the basic prerequisites of the technical & commercial process being followed at Stabicon. Its key input includes various segments of unmet needs in the Quality Management and address development, Analytical and services and innovation technology. Also a simplified business model along with our concept to completion laboratory design gives Stabicon additional efficiency & viability to our clients.
Wondering what Q4 Impact Group is all about? This presentation gives an in-depth overview of the Q4 competencies and the way we work to help you improve your profitability and solve difficult issues.
CRM and Multichannel experienced professional in the Life Sciences and Insurance verticlaes (among others). Looking to network and connect with other professionals with similar experience.
The basics of launching a pharmaceutical drug-
Based on studies done on the practices of 13 top pharmaceutical companies in the world.
For more, write to info@markivmedical.com
Concept to commercialization document gives an insight into the basic prerequisites of the technical & commercial process being followed at Stabicon. Its key input includes various segments of unmet needs in the Quality Management and address development, Analytical and services and innovation technology. Also a simplified business model along with our concept to completion laboratory design gives Stabicon additional efficiency & viability to our clients.
Wondering what Q4 Impact Group is all about? This presentation gives an in-depth overview of the Q4 competencies and the way we work to help you improve your profitability and solve difficult issues.
CRM and Multichannel experienced professional in the Life Sciences and Insurance verticlaes (among others). Looking to network and connect with other professionals with similar experience.
This was a proposal for a business plan for a company that I had once worked with that wanted to develop a long term business plan. I had worked with this company on TQM back in the 90's and they asked me to submit a proposal to help develop a business plan.
PSTRIDE Solutions LLP is your premier business partner for Life Science, Pharma, Biotech & Healthcare. We closely track vendors performance, new product feature, How they are implementing automation in their existing and new products and services through AI, Robotics, ML, NLP, RPA & Blockchain enabled services
PSTRIDE Solutions LLP is your premier business partner for Life Science, Pharma, Biotech & Healthcare. We closely track vendors performance, new product feature, How they are implementing automation in their existing and new products and services through AI, Robotics, ML, NLP, RPA & Blockchain enabled services
For pharmaceuticals and biotech companies, medical, legal, and regulatory reviews (MLRs) are commonplace, and help ensure that product claims, promotions, and training are medically correct, and in compliance with FDA and other industry standards. This requires companies to develop an MLR process that helps assure the accuracy, relevancy, and value of the promotional material they produce and market.
This presentation explains Right Lane's integrated approach to managing your growth strategy.
1. Articulate a clear growth strategy
2. Align your resources with your strategy
3. Actively lead the program
4. Adopt effective disciplines to manage the program
5. Build and maintain a fact base
2. ReCon Marketing Solutions
• A full service managed markets marketing communications firm
• Offering a comprehensive suite of products and services ranging from
strategy development to tactical implementation
• 40 proven and qualified staff members operating in the required work
streams: market research, project management, training, editorial,
creative design and technology solutions
• Staff integration and coordination overseen by the ReCon partners—
100% involvement, 100% of the time
• ReCon advantages vs other firms:
• Pharmaceutical and agency experience of the partners
• Relationships with managed markets decision makers
• Business model is specifically designed to ensure high quality and low 2
costs
8. ReCon Campaign Objectives
• Develop business plans for positioning portfolios long
term in light of clinical data and competition
• Develop and Differentiate clinical profile from major
competitors to translate into preferred formulary
status for current portfolio and new entrants
• Leverage the use of integrated special projects that
efficiently connect the Payers + Providers + Patients
8
11. Introducing The ReCon Rapid Survey
Answers for Questions That Will Not Wait
Turn Around - 10 Business Days
Managed Markets Audiences
Medical Directors
Pharmacy Directors
And More
10-15 Minute Survey, 45-55 Data Points
20 Completions
20 Page Report
Executive Summary
Key Findings, Conclusions, Recommendations
Objectives, Methodology, Findings in Detail
11
11
12. ReCon Rapid Survey
• Can be used as quick turnaround pulse surveys to
monitor a broad array of issues
• Pricing, packaging, value propositions, disease populations,
programs and initiatives
• Understand what payers value in terms of non-personal
communication
• ReCon often combines the RRC with a handful of qualitative IDIs
for a more complete view
• Can also be used as a baseline of information for a ReCon
Strategy Committee
• Capable of longer surveys when needed
12
13. The Survey
Developed in consultation with Client
Submit for Client review within one day
Revised, programmed, mounted on secure server in 3 days
Reviewed online by Client, revised as necessary and fielded Day 1
13
14. Preliminary Results
Twenty completions - survey closed Day 5
Preliminary results generated and sent to client Day 6
Reviewed with Client by conference call, need for IDIs identified Day 6
14
16. Introducing the ReCon
Strategy Committee
• Comprised of managed markets experts who are working outside of
health plans and PBMs but whose CVs establish them as widely
recognized US managed care experts:
• Past Presidents of AMCP
• Prolific authors on managed care topics
• Former Chief Medical and Pharmacy officers
• Nationally recognized managed care experts
• Healthplans
• Employers
• Business coalitions
• Hospitals and Integrated systems
• VA/DOD
16
17. Introducing the ReCon Strategy Committee
(cont)
The ReCon philosophy is to use smaller groups of managed care experts to
engage in rigorous series of working sessions to hammer out a managed
care marketing plan that is achievable. The emphasis here is on substance
over form and 100% engagement, preparedness and focus by all
participants
ReCon uses these select experts to:
• Develop Managed Care value propositions
• Uncover the drivers to adopting products in the managed markets
• Gain recommendations for messaging, and communications to payers
• Understand how to position products to the payer audience
• Gain feedback on best possible contracting scenarios
17
• Identify information needs and timing desired to ensure timeliness and
breadth of coverage policies to meet objectives
18. ReCon Mission
ReCon leverages its industry knowledge, relationships and
trust to identify strategic business opportunities for our
clients. This ability supports development of market
strategies and tactics to better position products for
optimum access and reimbursement within the complex
and highly managed healthcare marketplace.
18
19. ReCon Marketing Solutions
-Building on a foundation of expertise and success
Dean Reid
Partner, ReCon Marketing Solutions
7 Years – Executive VP Sales & Marketing
Managed markets and medical communications agency
17 Years Pharmaceutical Industry Experience
Regional Sales Director
National Account Director
Managed Care Marketing
Strategic Planning
Managed Care Sales Manager
19
Sales
20. ReCon Marketing Solutions
-Building on a foundation of expertise and success
Sal Cofoni
Partner, ReCon Marketing Solutions
8 Years – Executive VP & General Manager
Managed markets and medical communications agency
25 Years Pharmaceutical Industry Experience
Business Unit Director
Regional Sales Director
Co-founder of Managed Markets Department
Market Research
Sales Management 20
Corporate Sales Training
Sales
21. ReCon Marketing Solutions
-Building on a foundation of expertise and success
Dean Reid Sal Cofoni
856-596-7650 (O) 862-244-4316 (O)
609-744-5529 (M) 973-945-8260 (M)
deanreid@reid-cofoni.com salcofoni@reid-cofoni.com
21
Editor's Notes
ReCon Marketing Solutions is eager to serve you in a variety of unique capacities. As the ReCon name implies we are able to assist you in "finding" marketing solutions across the challenging pharmaceutical and biotechnology landscape.
Our combined, 50+ years of success in the pharmaceutical and agency fields translates into the ability to find, create and develop marketing concepts and tools to accelerate brand penetration and growth in a heavily managed healthcare market place.
Our combined, 50+ years of success in the pharmaceutical and agency fields translates into the ability to find, create and develop marketing concepts and tools to accelerate brand penetration and growth in a heavily managed healthcare market place.